Mohamed Elmeliegy

Mohamed Elmeliegy

Company: Pfizer

Job title: Associate Director - Clinical Pharmacology

Seminars:

Panel Discussion: Evaluating the Criteria Essential to Success in the Increasingly Competitive CD3 Bispecific Field 11:05 am

Discuss CD3 targeting approaches whilst sharing experiences in overcoming key challenges Gain insights and perspectives from stakeholders at a range of different stages of development in the field Benchmark your progress against a variety of companies and organizationsRead more

day: Pre-Conference Focus Day

An Industry Perspective on CD3 Bispecifics Starting Doses & Efficacious Dose Projections 11:50 am

• Strategies for selection of starting doses to balance patient safety and minimize patient’s exposure to subtherapeutic doses • Approaches for predicting efficacious doses • Challenges and opportunities for defining optimal biological doses for CD3 bispecificsRead more

day: Pre-Conference Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.